Cornerstone Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Cornerstone Wealth Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,855	Closed	-$312K	–	461
2020 Q4	$312K	Sell	1,855 -6,652	-78%	-$1.08M	0.04%	328
2020 Q3	$1.34M	Sell	8,507 -513	-6%	-$83.9K	0.2%	101
2020 Q2	$1.51M	Buy	+9,020	New	+$1.42M	0.24%	82
2019 Q2	–	Sell	-842	Closed	-$336K	–	404
2019 Q1	$336K	Buy	+842	New	+$121K	0.04%	356
2018 Q3	–	Sell	-1,078,165	Closed	-$7.62M	–	1377
2018 Q2	$7.62M	Buy	1,078,165 +1,070,519	+14,001%	+$147M	0.09%	241
2018 Q1	$967K	Buy	+7,646	New	+$1.04M	0.18%	114

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Cornerstone Wealth Management's FBT Position: Q1 2021 in Review

Cornerstone Wealth Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2021, closing a stake of 1,855 shares — an estimated $312K sold.

Cornerstone Wealth Management first reported a position in FBT in Q1 2018 and held it in 6 quarters. The position peaked at $7.62M in Q2 2018. 236 funds tracked by Wall St. Rank hold FBT as of Q1 2021.

Cornerstone Wealth Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2021 after selling out during the quarter.
Cornerstone Wealth Management sold 1,855 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2021, an estimated $312K.
Cornerstone Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2018 and held it in 6 quarters.
Cornerstone Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $7.62M in Q2 2018.
236 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2021.

Based on Cornerstone Wealth Management's 13F filing for Q1 2021, filed 30 Apr 2021.